Author Login IJIRT Partner Network (IPN) Login

BILASTINE: A DRUG REVIEW

  • Unique Paper ID: 157524
  • Volume: 9
  • Issue: 7
  • PageNo: 469-473
  • Abstract:
  • An effective and highly specific H1-antihistamine, bilastine is licenced to treat allergic urticaria and rhinoconjunctivitis. The information that is currently known on the use of bilastine in the treatment of allergic diseases in various age groups, including school-age children and adolescents, younger and older people, is included in this page. Adults and adolescents over the age of 12 get oral bilastine at a dose of 20 mg once day, while children between the ages of 6 and 12 receive oral bilastine at a dose of 10 mg once daily. Clinical studies have shown that it is effective at reducing wheals and itching in urticaria patients as well as nasal and ocular symptoms in people with allergic rhinitis. It acts quickly and effectively for a long time. Bilastine's potential for drug-drug interactions is constrained because it does not undergo considerable metabolism and does not interact with the CYP450 system. In individuals with renal or hepatic impairment, as well as in the elderly, there are no dose changes necessary. Bilastine is often well tolerated, even when given in dosages that are beyond the recommended amount. It has very little sedative effects and neither anticholinergic nor cardiotoxic effects, nor does it penetrate the central nervous system. It has been demonstrated to enhance life quality as it relates to health. From school-age children to senior patients, bilastine is an useful alternative for the treatment of individuals with allergic rhinoconjunctivitis or urticaria.
Download article email to a friend

Cite This Article

  • ISSN: 2349-6002
  • Volume: 9
  • Issue: 7
  • PageNo: 469-473

BILASTINE: A DRUG REVIEW

Related Articles

Impact Factor
8.01 (Year 2024)
UGC Approved
Journal no 47859

Join Our IPN

IJIRT Partner Network

Submit your research paper and those of your network (friends, colleagues, or peers) through your IPN account, and receive 800 INR for each paper that gets published.

Join Now

Latest Publication

Archive

View More

Recent Conferences

NCSEM 2024

National Conference on Sustainable Engineering and Management - 2024 Last Date: 15th March 2024

Submit inquiry